SCHEMBL6696152

SCHEMBL6696152

CCc1cccn1Cc1ccc(-c2ccccc2Br)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 6/20 0.44
HDAC6 Q9UBN7 5/20 0.44
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 1/20 0.41
ITGB1 P05556 3/20 0.35
ITGA4 P13612 3/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
AGTR1 P30556 1/20 0.35
AGTR2 P50052 1/20 0.35
PPARG P37231 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
EGFR P00533 1/20 0.33
MET P08581 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3195611 0.78 HDAC8 (0.49) HDAC8HDAC6ALDH1A1KDM4ELMNA
SCHEMBL6700771 0.78 DHPS (0.48) HDAC8HDAC6AGTR1AGTR2CYP11B1
SCHEMBL12514860 0.76 ALDH1A1 (0.58) ALDH1A1MAPK1KDM4EEGFRLMNA
SCHEMBL6695778 0.73 MAPK1 (0.50) HDAC8HDAC6ALDH1A1MAPK1PPARG
SCHEMBL3202371 0.73 CYP11B1 (0.45) ALDH1A1KDM4EMEN1KMT2ACYP11B1
SCHEMBL6691960 0.72 HTR6 (0.59) HDAC8HDAC6ALDH1A1MAPK1KMT2A
SCHEMBL6226587 0.71 CHRM1 (0.41) HDAC8HDAC6
SCHEMBL6225743 0.71 CA12 (0.56) HDAC6ALDH1A1MAPK1KDM4EMEN1
SCHEMBL6696330 0.69 HDAC8 (0.46) HDAC8HDAC6PPARGHDAC3HDAC4
SCHEMBL1249731 0.69 MAPK1 (0.58) ALDH1A1MAPK1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040229874-A1 5HT7 Antagonists and inverse agonists PFIZER INC. 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229874-A1 5HT7 Antagonists and inverse agonists HTR7, HTR1A, HTR1B HDAC8 2221/4885HDAC6 1841/4885ALDH1A1 1099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.